Q8RHY5 AF NFT

Glutamate mutase epsilon subunit

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeiensgskxejzsdn4ia3yk6b4ldr7odgyld5pse5yxa6lex73b6x24u/metadata.json
IPFS of structure file: 
bafybeigpjqkpwk2wsuyiljvc62y5bjbfxcq2va3hapts3bd5sxkb6oswx4/AF-Q8RHY5-F1-model_v2.pdb
First NFT owner address (eip-55): 
0xF79B1412c231995428684e6fF0B9579F29BC308e
First NFT owner address (bech32): 
genesis177d3gykzxxv4g2rgfehlpw2hnu5mcvyw55ndek
Current NFT ID #149318 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1_w

NFT id:
149318
Accession (UniProt):
Q8RHY5
Name::
Glutamate mutase epsilon subunit
Experimental Method:
Predicted structure
Sequence source:
Fusobacterium nucleatum subsp. nucleatum (strain ATCC 25586 / DSM 15643 / BCRC 10681 / CIP 101130 / JCM 8532 / KCTC 2640 / LMG 13131 / VPI 4355)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT Q8RHY5 research and analysis (ICN3D with VR)

FASTA sequences

>sp|Q8RHY5|GLME_FUSNN Glutamate mutase epsilon subunit OS=Fusobacterium nucleatum subsp. nucleatum (strain ATCC 25586 / DSM 15643 / BCRC 10681 / CIP 101130 / JCM 8532 / KCTC 2640 / LMG 13131 / VPI 4355) OX=190304 GN=glmE PE=3 SV=1 MPITFKKIDKEDFLEIRKNFLENYKNLDDFDLNTAIRFHKSLPDHKNFQKKIEQSVQDNKIMTQAHSKETLLEDLIKNLNTFYRVGQADFLSIIIDSHTRENHYDNAKVILEDSIKSNKSLLNGFPLINYGTKLARKIINDVEVPLQIKHGSPDARLLVEVALLSGFSAFDGGGISHNIPFSKSISLKDSLENWKYVDRLVGIYEENGIKINREIFSPLTATLVPPAISNSIQILETLLAVEQGVKNISIGVAQYGNITQDIASLLALKEHIQFYLDTFSFKDINISTVFNQWIGGFPEEELKAYSLISYSTTIALFSKTNRIFVKNIDEYAKNSLGNTMINSLLLTKTILDIGNNQKINNYEEIIFEKEQIKKETAQIIAKIFSRCDGDLRKAIIEAFEYGVLDVPFAPSKYNLGKMMPARDSEGMIRYLDIGNLPFCPLIEEFHNKKIKERSMKENREINFQMTIDDIFAMSQGKLINKKSRE